公开(公告)号：US20230233480A1

公开(公告)日：2023-07-27

申请号：US17769548

申请日：2020-10-21

Applicant: LTS LOHMANN THERAPIE-SYSTEME AG

Inventor： Florian HAMMES ,  Anja TOMELERI ,  Tobias KLEUDGEN

IPC: A61K9/70 ,  A61K31/137 ,  A61K47/38 ,  A61K47/10 ,  A61K47/34 ,  A61K47/32 ,  A61F13/15

CPC classification number: A61K9/7084 ,  A61K31/137 ,  A61K47/38 ,  A61K47/10 ,  A61K47/34 ,  A61K47/32 ,  A61F13/15 ,  A61F2013/0296

Abstract: The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of fingolimod.

公开(公告)号：US20230285323A1

公开(公告)日：2023-09-14

申请号：US18019505

申请日：2021-07-22

Applicant: LTS LOHMANN THERAPIE-SYSTEME AG

Inventor： Florian HAMMES ,  Anja TOMELERI ,  Tobias KLEUDGEN

IPC: A61K31/135 ,  A61K9/70 ,  A61K47/14 ,  A61K47/12 ,  A61K47/10

CPC classification number: A61K31/135 ,  A61K9/7069 ,  A61K47/14 ,  A61K47/12 ,  A61K47/10

Abstract: The present invention concerns a transdermal therapeutic system, comprising a backing layer, which is not permeable N for the active ingredient, and at least one matrix layer on one side of the backing layer, wherein the matrix layer contains at least one pressure sensitive adhesive and ketamine or a pharmaceutically acceptable salt or solvate thereof, wherein the at least one pressure sensitive adhesive comprises a silicone pressure sensitive adhesive, as well as its use as medicament, in particular for the treatment of depression and pain.

公开(公告)号：US20200330404A1

公开(公告)日：2020-10-22

申请号：US16386458

申请日：2019-04-17

Applicant: LTS LOHMANN Therapie-Systeme AG

Inventor： Florian Hammes ,  Tobias KLEUDGEN ,  Anja TOMELERI

IPC: A61K31/135 ,  A61K9/70

Abstract: The present invention concerns a transdermal therapeutic system, comprising a backing layer, which is not permeable for the active ingredient, and a matrix layer on one side of the backing layer, wherein the matrix layer contains at least one pressure sensitive adhesive and ketamine or a pharmaceutically acceptable salt or solvate thereof, wherein the at least one pressure sensitive adhesive has free hydroxyl groups, as well as its use as medicament, in particular for the treatment of depression and pain.

公开(公告)号：US20220241218A1

公开(公告)日：2022-08-04

申请号：US17603885

申请日：2020-04-17

Applicant: LTS LOHMANN THERAPIE-SYSTEME AG

Inventor： Florian HAMMES ,  Tobias KLEUDGEN ,  Anja TOMELERI

IPC: A61K31/135 ,  A61K9/70

Abstract: The present invention concerns a transdermal therapeutic system, comprising a backing layer, which is not permeable for the active ingredient, and a matrix layer on one side of the backing layer, wherein the matrix layer contains at least one pressure sensitive adhesive and ketamine or a pharmaceutically acceptable salt or solvate thereof, wherein the at least one pressure sensitive adhesive has free hydroxyl groups, as well as its use as medicament, in particular for the treatment of depression and pain.

公开(公告)号：US20220096393A1

公开(公告)日：2022-03-31

申请号：US17295101

申请日：2019-11-20

Applicant: LTS Lohmann Therapie-Systeme AG

Inventor： Florian HAMMES ,  Anja TOMELERI ,  Tobias KLEUDGEN

IPC: A61K9/70

Abstract: The invention relates to a system containing: a transdermal therapeutic system (TTS); a cylindrical separating layer having an outer periphery and an inner periphery; and a backing layer, which is applied to the cylindrical separating layer and protrudes beyond the cylindrical separating layer over the entire periphery. The invention further relates to a system for improving the adhesion of a TTS, to the use of the system, and to a kit containing the system.

公开(公告)号：US20190134254A1

公开(公告)日：2019-05-09

申请号：US16239862

申请日：2019-01-04

Applicant: LTS Lohmann Therapie-Systeme AG

Inventor： Michael HORSTMANN ,  Christian HAUSEN ,  Patrick MOHR ,  Karin LUDWIG ,  Tobias KLEUDGEN

IPC: A61L15/44 ,  A61L15/58 ,  A61L15/24

Abstract: The present invention relates to adhesive bandages provided with a water-vapor permeable back layer and an adhesive layer, in which the adhesive layer includes 10 weight percent of a disperse internal phase of hydrophilic particles that are water-swellable in an outer phase that includes at least 10 weight percent of a styrene block copolymer and at least 20 weight percent of an ester resin of colophony, and that can further contain at least one anti-virus substance.

公开(公告)号：US20250082584A1

公开(公告)日：2025-03-13

申请号：US18728006

申请日：2023-01-26

Applicant: LTS LOHMANN THERAPIE-SYSTEME AG

Inventor： Florian HAMMES ,  Anja TOMELERI ,  Tobias KLEUDGEN

IPC: A61K9/70 ,  A61K31/4965

Abstract: The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of selexipag.